Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

As tough as it may be to do right now, this is a great time to hold your nose and dive in while yields are as high as they are.

Pfizer's stock rose 0.48% in its latest trading session, outperforming the S&P 500's 0.13% uptick, while other indices ...

In the latest trading session, Pfizer (PFE) closed at $22.15, marking a +0.48% move from the previous day. The stock exceeded the S&P 500, which registered a gain of 0.13% for the day. On the other ...

We recently published a list of 15 Best Large-Cap Value Stocks to Buy as the Recession Hits. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other best ...

As in previous studies, the SHIELD study found health care workers who received the Novavax vaccine reported significantly ...

Sell Now on ET Now offers expert stock market tips, helping investors navigate market trends. The show addresses viewer queries, providing insights on buying and selling strategies, and offers timely ...

Pfizer (NYSE:PFE) recently announced the cessation of Danuglipron's development, an event that coincided with a 3% decline in ...

Here's why the stock is worth considering today. The Trump administration has so far exempted pharmaceuticals from its announced tariffs, but the industry has faced repeated threats of future tariffs.

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Pfizer has discontinued its experimental weight-loss pill danuglipron after a trial patient experienced potential ...

Goldman maintains two custom equity baskets, each with 50 stocks from the Russell 1000 Index, to monitor this trend. The firm rebalanced both baskets, including the High Liquidity (GSTHLLIQ) portfolio ...